nafazatrom has been researched along with Arrhythmias, Cardiac in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Coker, SJ; Parratt, JR | 2 |
Fiedler, VB | 2 |
4 other study(ies) available for nafazatrom and Arrhythmias, Cardiac
Article | Year |
---|---|
The effects of nafazatrom on arrhythmias and prostanoid release during coronary artery occlusion and reperfusion in anaesthetized greyhounds.
Topics: 6-Ketoprostaglandin F1 alpha; Anesthesia; Animals; Arrhythmias, Cardiac; Coronary Disease; Dogs; Epoprostenol; Female; Fibrinolytic Agents; Male; Perfusion; Prostaglandins; Pyrazoles; Pyrazolones; Thromboxane B2 | 1984 |
Reduction of myocardial infarction and dysrhythmic activity by nafazatrom in the conscious rat.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Vessels; Male; Myocardial Infarction; Pyrazoles; Pyrazolones; Rats; Rats, Inbred Strains | 1983 |
Arachidonic acid cascade and the generation of ischemia- and reperfusion-induced ventricular arrhythmias.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Arrhythmias, Cardiac; Coronary Disease; Dogs; Epoprostenol; Iloprost; Norepinephrine; Perfusion; Pyrazoles; Pyrazolones; Receptors, Prostaglandin; Receptors, Thromboxane; Thromboxanes | 1985 |
Failure of nafazatrom to reduce infarct size and arrhythmias in a porcine model of acute coronary occlusion.
Topics: Animals; Arachidonate Lipoxygenases; Arrhythmias, Cardiac; Female; Fibrinolytic Agents; Hemodynamics; Lipoxygenase Inhibitors; Male; Myocardial Infarction; Pyrazoles; Pyrazolones; Swine | 1985 |